CLEAR Program Physician Webpage
Information specifically for physicians to help your patient understand PAD
Built on the Strength of Armada™ Family of Balloons Dilatation Catheters
For more than 15 years, the Armada™ Family of Balloon Dilatation Catheters has supported physicians across a broad range of peripheral interventions. Backed by years of clinical use and a comprehensive BTK portfolio, Armada™ continues to support physicians treating complex lesions.
Today, that legacy expands with the introduction of Armada™ 14 NC PTA Catheter.
Comprehensive 0.014" Balloon Portfolio with the latest addition to the Armada™ 14 Family
Differences are highlighted in green and blue.
- 15+ Years of Clinical Experience
- Extensive Global Use
- Trusted Armada™ PTA Catheters Platform
Today's Challenges Demand More
BTK interventions often involve challenging anatomy, resistant and calcified lesions, and increasingly demanding treatment strategies.
Introducing Armada™ 14 NC PTA Catheter
Armada™ 14 NC PTA Catheter is a high-pressure (20 atm RBP), non-compliant balloon designed for uniform, controlled expansion1 to reduce vessel injury2 in CLTI procedures.3 It delivers exceptional performance through its low crossing and tip profile and outstanding deliverability.
Confidence Under Pressure
Controlled Expansion
at High Pressure
Outstanding
Deliverability
Designed for the
Esprit™ BTK System
Why Armada™ 14 NC PTA Catheter Matters
- Controlled high-pressure (20 atm RBP) and non-compliance for effective expansion while helping reduce elastic recoil3
- Engineered to inflate uniformly along its length and prevents dog-bone effect4
| Semi-compliant balloons | Non-compliant balloons | |||
|---|---|---|---|---|
| Attribute | Impact | Attribute | Impact | |
| Pressure | Low pressure | ~ 14 ATM | High pressure | > 14 ATM |
| Elasticity (diameter growth as pressure increases) | More elastic |
| Less elastic |
|
| Pressure + Elasticity | Lower pressure + more elastic (combo) |
| High pressure + low elastic (combo) |
|
Explore Armada™ 14 NC PTA Catheter
Features
Sharing Information, Promoting Understanding: Resources to Help Your Patients Walk Away from PAD/CLTI
Beyond the treatment, make sure your referring physicians are fully aware of PAD and CLTI and how they can help with early diagnosis and timely treatment. For information specifically for the physician, visit our CLEAR Program webpage. Access a full range of helpful tools and insights. And for your patients, refer them to the PAD Patient Webpage link to support the work you do, so they can learn about PAD symptoms and access an educational brochure.
References
CLTI: Chronic limb-threatening ischemia.
*Esprit™ BTK Everolimus Resorbable Scaffold System.
Note: Drawing not to scale. Data on file at Abbott. Benchtop testing may not be indicative of clinical performance.
- Cuculi F, et al. Open Heart 2020;7:e001204
- Romagnoli E, et al. JACC Cardiovasc Interv. 2008;1(1):22-31.
- Huizing E, et al. International Angiology. 2020;39(5):390-7.
- Giuseppe V, et al. Catheter Cardiovasc Interv. 2019;94:E111–E115
MAT-2677860 v2.0